Volume 63, Issue 4, Pages (April 2013)

Slides:

Advertisements

Similar presentations

Volume 45, Issue 5, Pages (May 2004)

Advertisements

Volume 56, Issue 5, Pages (November 2009)

Fear of crime and psychological and physical abuse associated with ill health in a Swedish population aged 65–84 years N. Olofsson, K. Lindqvist, I.

Volume 72, Issue 1, Pages (July 2017)

Volume 68, Issue 2, Pages (August 2015)

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 4, Pages (April 2008)

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Let the Games Begin (with EAU Approval)

Volume 49, Issue 5, Pages (May 2006)

Prostate Cancer Epidemic in Sight?

Volume 45, Issue 4, Pages (April 2004)

Volume 74, Issue 1, Pages (July 2018)

Bladder Cancer: A Major Public Health Issue

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 5, Pages (November 2015)

Prostate Cancer Detection: A View of the Future

Volume 54, Issue 5, Pages (November 2008)

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 63, Issue 5, Pages (May 2013)

Volume 69, Issue 3, Pages (March 2016)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 73, Issue 4, Pages (April 2018)

Prostate Cancer Epidemic in Sight?

Global Burden of Urologic Cancers, 1990–2013

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 62, Issue 4, Pages (October 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 63, Issue 3, Pages (March 2013)

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 50, Issue 5, Pages (November 2006)

Volume 58, Issue 3, Pages (September 2010)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,

Testicular Cancer Variations in Time and Space in Europe

Volume 59, Issue 4, Pages (April 2011)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Volume 72, Issue 1, Pages (July 2017)

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Economic Burden of Bladder Cancer Across the European Union

Volume 68, Issue 2, Pages (August 2015)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 51, Issue 2, Pages (February 2007)

European Lung Cancer Conference (ELCC) 2016 Organisation

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Epidemiology and Demographics of Prostatitis

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years Xinxin Guo, Svante Östling, Silke.

Presentation transcript:

Volume 63, Issue 4, Pages 733-738 (April 2013) Childbearing and the Risk of Bladder Cancer: A Nationwide Population-based Cohort Study Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe European Urology Volume 63, Issue 4, Pages 733-738 (April 2013) DOI: 10.1016/j.eururo.2013.01.005 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Incidence rates of bladder cancer per 100 000 person-years by age for men and women in Sweden (based on NORDCAN data from 1963 to 2009 [1]). Orange=males, blue=females. European Urology 2013 63, 733-738DOI: (10.1016/j.eururo.2013.01.005) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 2 Incidence rate ratios of bladder cancer comparing women with one, two or three or more children with different ages at first birth with nulliparous women in a Cox proportional hazards model adjusted for attained age, highest educational level, and chronic obstructive lung disease. European Urology 2013 63, 733-738DOI: (10.1016/j.eururo.2013.01.005) Copyright © 2013 European Association of Urology Terms and Conditions